FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the FDA said.

  News   Mar 9, 2024   0   48  Add to Reading List
FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

ARE YOU TIRED OF LOW SALES TODAY?

Connect to more customers on doacWeb

Post your business here..... from NGN1,000

WhatsApp: 09031633831

ARE YOU TIRED OF LOW SALES TODAY?

Connect to more customers on doacWeb

Post your business here..... from NGN1,000

WhatsApp: 09031633831

ARE YOU TIRED OF LOW SALES TODAY?

Connect to more customers on doacWeb

Post your business here..... from NGN1,000

WhatsApp: 09031633831

This image provided by Novo Nordisk in January 2023 shows packaging for the company

The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the FDA said.

Read Original   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow